Dr. Yang Li 李阳
Chief Physician
Department of Breast Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive breast surgery, breast-conserving surgery with reconstruction, and mastectomy. Early diagnosis and treatment of breast cancer, including sentinel lymph node biopsy, chemotherapy, endocrine therapy, targeted therapy, radiotherapy, and palliative care for advanced cases.
Dr. Li is a Chief Physician in the Department of Breast Surgery at Liaoning Cancer Hospital & Institute and holds a medical doctorate. With nearly 20 years of clinical experience, Dr. Li supervises master’s students at China Medical University. Research includes one provincial natural science fund project and multiple national and provincial studies. Dr. Li has published eight SCI articles, including five as first author.
Professional roles
- Master’s Supervisor, China Medical University
- Council Member, Breast Cancer Professional Committee, Liaoning Society for Cell Biology
- Member, Second Breast Reconstruction and Aesthetics Professional Committee, Liaoning Life Science Society
- Committee Member, First Individualized Diagnosis and MDT Professional Committee for Breast Cancer, Beijing Cancer Prevention and Treatment Association
Name order: in Chinese the family name comes first (Li Yang). Papers usually list the name as Yang Li or Li Y.
Selected publications
20 papers on PubMed matched by name and affiliation; 2 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Mol Med, 2024 (first author): [Retracted] Ubiquitin‑specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4. PubMed 39219282
- Int J Mol Med, 2016 (first author): Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4. PubMed 27430936
- J Chromatogr Sci, 2015 (first author): Validation of an HPLC-MS-MS assay for determination of morellic acid in rat plasma: application to pharmacokinetic studies. PubMed 26071609
- Biomed Chromatogr, 2014 (first author): LC-ESI-MS/MS analysis and pharmacokinetics of jolkinolide B, a potential antitumor active component isolated from Euphorbia fischeriana, in rat plasma. PubMed 23868721
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion